Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.

Keywords

Ceruloplasmin, Internal medicine, Endocrinology, Parkinson's disease, Medicine

References

• Plasma-Based Circulating MicroRNA Biomarkers for Parkinson's DiseaseSok Kean Khoo, David Petillo, Un Jung Kang — 2012
• Ceruloplasmin Regulates Iron Levels in the CNS and Prevents Free Radical InjuryBharatkumar N. Patel, Robert Dunn, Suh Young Jeong — 2002
• MicroRNAs in Parkinson's disease.M. Maral Mouradian — 2012
• Ceruloplasmin Oxidation, a Feature of Parkinson's Disease CSF, Inhibits Ferroxidase Activity and Promotes Cellular Iron RetentionStefano Olivieri, Antonio Conti, Sandro Iannaccone — 2011
• Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinson's disease.Lirong Jin, Jian Wang, Lei Zhao — 2011
• Diagnostic criteria for Parkinson disease.Douglas J. Gelb, Eugene Oliver, Sid Gilman — 1999
• A MicroRNA Feedback Circuit in Midbrain Dopamine NeuronsJong‐Pil Kim, Keiichi Inoue, Jennifer Ishii — 2007
• MicroRNAs in Parkinson’s DiseaseMaged M. Harraz, Ted M. Dawson, Valina L. Dawson — 2011
• Plasma Ceruloplasmin Ferroxidase Activity Correlates with the Nigral Sonographic Area in Parkinson’s Disease Patients: A Pilot StudyRubén Martínez-Hernández, Sergio Montes, Jesús Higuera‐Calleja — 2011
• Glycosylphosphatidylinositol-anchored Ceruloplasmin Is Required for Iron Efflux from Cells in the Central Nervous System*Suh Young Jeong, Samuel David — 2003
• Lower serum ceruloplasmin levels correlate with younger age of onset in Parkinson’s diseaseKersi J. Bharucha, Joseph H. Friedman, Andrea S. Vincent — 2008
• ParkinsonismMargaret M. Hoehn, Melvin D. Yahr — 1967
• Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface.Liliana Marques, A Auriac, Alexandra Willemetz — 2012
• Reduced ferroxidase activity in the cerebrospinal fluid from patients with Parkinson's disease.Marie‐Catherine Boll, Julio Sotelo, Enrique Otero — 1999
• Hypoceruloplasminemia‐related movement disorder without Kayser‐Fleischer rings is different from Wilson disease and not involved in ATP7B mutationJ. Lirong, J. Jianjun, Zhixiang Hua — 2009
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.Benjamin P. Lewis, Christopher B. Burge, David P. Bartel — 2005
• Normal Midbrain Dopaminergic Neuron Development and Function in miR-133b Mutant MiceMary P. Heyer, Amar K. Pani, Richard J. Smeyne — 2012
• Is Parkinson's disease the heterozygote form of Wilson's disease: PD = 1/2 WD?Susan R. Johnson — 2001
• Nigral iron deposition occurs across motor phenotypes of Parkinson’s diseaseLirong Jin, J. Wang, Hang Jin — 2012
• Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.Z. Leah Harris, Yoshitomo Takahashi, Hiroaki Miyajima — 1995

Cited by

• Serum miR‐221 serves as a biomarker for Parkinson's diseaseFrancisco Candel Crespo — 2016
• Identification of altered microRNAs in serum of a mouse model of Parkinson's disease.Червонюк Владимир Иванович — 2018
• Use of miRNAs as Biomarkers in SepsisRaluca Dumache, Alexandru Florin Rogobete, Ovidiu Horea Bedreag — 2015
• Ceruloplasmin is Involved in the Nigral Iron Accumulation of 6-OHDA-Lesioned RatsJun Wang, Mingxia Bi, Junxia Xie — 2015
• MicroRNA machinery in Parkinson’s disease: a platform for neurodegenerative diseasesAmene Saghazadeh, Nima Rezaei — 2015
• Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.Haixia Ding, Zhen Huang, Mengjie Chen — 2016
• MiR-133b ameliorates axon degeneration induced by MPP(+) via targeting RhoA.Minzhu Niu, Ruyan Xu, Jing‐hui Wang — 2016
• Epigenetics Involvement In Parkinson's Disease And Manganese-Induced NeurotoxicityCheng Peng, Yang Qiao, Jack Ng — 2015
• Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133bQun-Ying Zhuang, Tengjian Zhou, Chengyong He — 2016
• An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's DiseasesMeire Silva Batistela, Nalini Drieli Josviak, Carla Daniela Sulzbach — 2017
• Novel microRNA discovery using small RNA sequencing in post-mortem human brainChristian Wake, Adam Labadorf, Alexandra Dumitriu — 2016
• Exploring MicroRNAs on NIX-Dependent Mitophagy.Wen Li, Hao Chen, Shupeng Li — 2018
• MicroRNAs in Parkinson’s diseaseAbhishek Singh, Dwaipayan Sen — 2017
• Reduced Circulating Levels of miR-433 and miR-133b Are Potential Biomarkers for Parkinson’s DiseaseXiong Zhang, Rui Yang, Beilei Hu — 2017
• Endogenous non-enzymatic antioxidants in the human body.Iwona Mirończuk-Chodakowska, Anna Maria Witkowska, Małgorzata Elżbieta Zujko — 2018
• MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson DiseaseAhmad Rasyadan Arshad, Siti Aishah Sulaiman, Amalia A. Saperi — 2017
• Comparison of diagnosis of VUR nephropathy by urinary level of ceruloplasmin with DMSA-Scan in childrenM. A. Sepahi, M. Heidari, M. Haeri — 2017
• Microarray Analysis of the Molecular Mechanism Involved in Parkinson's DiseaseCheng Yong Tan, Xiaoyang Liu, Jiajun Chen — 2018
• MiR-181b regulates autophagy in a model of Parkinson's disease by targeting the PTEN/Akt/mTOR signaling pathway.Wei Li, Yongmei Jiang, Yuan Wang — 2018
• Diversity and signature of small RNA in different bodily fluids using next generation sequencingMohamed El-Mogy, Bernard Lam, Taha Haj-Ahmad — 2018

Related papers

• Decreased ceruloplasmin ferroxidase activity in cigarette smokers.Pacht Er, Davis Wb — 1988
• Utility of ferroxidase activity assay in the diagnosis of aceruloplasminemia with detectable serum ceruloplasmin levelsDaisuke Inoue, Tatsuo Mano, Aki Mitsue — 2017
• Identification of apo- and holo-forms of ceruloplasmin in patients with Wilson's disease using native polyacrylamide gel electrophoresis.Kazuya Hirano, Tohru Ogihara, Hiromi Ogihara — 2005
• The Ceruloplasmin Transferrin Ratio in the Blood of Patients at Different Stages of Parkinson’s DiseaseM. G. Makletsova, G. T. Rikhireva, Vsevolod V. Poleschuk — 2017
• Analysis on the Effect of Heavy Metals and Genetics on the Prevalence of Parkinson’s DiseaseChen‐Yu Zhang — 2020
• Parkinson’s Disease-OverviewFariha Khaliq — 2021
• [The experimental models of Parkinson's disease in animals].Grigor'ian Ga, Bazian As — 2007